Novartis AG is 46.3x more valuable than Terns Pharmaceuticals, Inc. by market capitalization ($283.13 B vs $6.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TERN | NVS |
|---|---|---|
| Market cap | $6.12 B | $283.13 B |
| US-listed rank | #1249 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$96.21M | - |
| SEC filings | 430 | 947 |
Novartis AG is 46.3x more valuable than Terns Pharmaceuticals, Inc. by market capitalization ($283.13 B vs $6.12 B).
Full pages: Terns Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.